Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2007

01-05-2007 | Case Report

Celiac Disease Is Not Associated with Chronic Hepatitis C

Authors: Thierry Thevenot, Arnaud Boruchowicz, Jean Henrion, Bernard Nalet, Henri Moindrot, ANGH

Published in: Digestive Diseases and Sciences | Issue 5/2007

Login to get access

Excerpt

Celiac disease (CD) is characterized by malabsorption due to a local immune response to dietary gluten against the mucosa of the small intestine in genetically predisposed patients bearing the human leukocyte antigen (HLA) DR3-DQ2 or DR4-DQ8. CD has a wide spectrum of gastrointestinal and extraintestinal manifestations, including dermatitis herpetiformis, type 1 diabetes mellitus, and autoimmune thyroiditis [1]. It has been hypothesized that hepatitis C virus (HCV) may trigger immunologic gluten intolerance in susceptible people [2]. However, this assumption is still a matter of debate. Recently, we diagnosed four patients having both CD and chronic hepatitis C, three of them having a well-defined route of transmission, suggesting that there is no obvious link between the two diseases. …
Literature
1.
2.
Fine KD, Ogunji F, Saloum Y, et al. (2001) Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 96:138–145PubMedCrossRef
3.
Chiang BL, Yang PM, Hwang LH, et al. (1998) Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C. J Biomed Sci 5:290–296PubMedCrossRef
4.
Michalski JP, McCombs CC, Arai T, et al. (1996) HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens 47:127–133PubMedCrossRef
5.
Bardella MT, Marino R, Meroni PL (1999) Celiac disease during interferon treatment. Ann Intern Med 131:157–158PubMed
6.
Cammarota G, Cuoco L, Cianci R, et al. (2000) Onset of celiac disease during treatment with interferon for chronic hepatitis C. Lancet 3556:1494–1495CrossRef
7.
Bourliere M, Oules V, Perrier H, et al. (2001) Onset of coeliac disease and interferon treatment. Lancet 357:803–804PubMedCrossRef
8.
Adinolfi LE, Durante-Mangoni E, Andreana A (2001) Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 96:607–608PubMedCrossRef
9.
Nadir A, Van Thiel DH (2003) Celiac disease in patients with HCV genotype 1A. Am J Gastroenterol 98:940–941PubMedCrossRef
10.
Colombo E, Cermesoni L, Morganti D (2003) Celiac sprue: another autoimmune syndrome associated with hepatitis C? Dig Liver Dis 35:64–65PubMedCrossRef
11.
Narvaez I, Perez B, del Mar Alcalde M, et al. (2003) Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease. Am J Gastroenterol 98:2336–2337PubMedCrossRef
12.
Aguancha I, Valera JM, Hurtado C, et al. (2004) Chronic hepatitis C and celiac sprue: an infrequent association. Gastroenterol Hepatol 27:408–410PubMedCrossRef
13.
Martins EV, Gaburri AK (2004) Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C. Arq Gastroenterol 41:132–133PubMedCrossRef
14.
Casella G, Bardella MT, Perego D, et al. (2004) Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C? Eur J Gastroenterol Hepatol 16:429PubMedCrossRef
15.
Borghi-Scoazec G, Merle P, Scoazec JY, et al. (2004) Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C. J Hepatol 40:871–872PubMedCrossRef
16.
Durante-Mangoni E, Iardino P, Resse M, et al. (2004) Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 38:901–905PubMedCrossRef
17.
Teml A, Vogelsang H (2001) Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 96:2522–2523PubMedCrossRef
18.
Thevenot T, Denis J, Jouannaud V, et al. (2006) Prevalence of celiac disease in chronic hepatitis C: a multicenter prospective study. Gastroenterol Clin Biol 30:157A
Metadata
Title
Celiac Disease Is Not Associated with Chronic Hepatitis C
Authors
Thierry Thevenot
Arnaud Boruchowicz
Jean Henrion
Bernard Nalet
Henri Moindrot
ANGH
Publication date
01-05-2007
Published in
Digestive Diseases and Sciences / Issue 5/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9360-5

Other articles of this Issue 5/2007

Digestive Diseases and Sciences 5/2007 Go to the issue

Original Paper

Transcutaneous Electrical Nerve Stimulation (TENS) Improves Upper GI Symptoms and Balances the Sympathovagal Activity in Scleroderma Patients

Review Article

Left-Sided Portal Hypertension

Original Paper

Diagnostic Yield and Impact of Capsule Endoscopy on Management of Patients with Gastrointestinal Bleeding of Obscure Origin

Original Paper

Gastric Tissue Oxidative Changes in Portal Hypertension and Cirrhosis

Case Report

Acquired Poststenotic Jejunal Diverticulosis

Original Paper

Correlation of Clinical and Histopathological with Endoscopic Findings of Celiac Disease in the Turkish Population
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits